Cancer Research UK and AstraZeneca have announced that they are opening a new centre in the Milner Research Labs in Cambridge, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer. The...
From 6 organisations in 2015 to 65 organisations in 2017, the alliance enables partnerships between pharma, biotech, service providers and academia Cambridge, 3 October 2017 – The Milner Therapeutics Institute at the University of Cambridge announces 65 organisations...
Press Release Cambridge, 19 January 2017 – The Milner Therapeutics Institute announces Pfizer as a new partner joining the Consortium to develop mutually-beneficial collaborations with Cambridge academics and the Milner Therapeutics Institute. Pfizer joins Astex,...
